ISKNV in aquariums: screen without shortcuts

ISKNV in aquariums: screen without shortcuts

ISKNV may arrive with tropical fish showing few specific signs. A new LAMP assay accelerates screening, but still requires field validation.

Content type
Disease profile
Sector
Public aquariums
Animal group
Fish
Theme
DiseasesBiosecurity

A dark, lethargic or anorexic tropical fish does not identify a megalocytivirus. These signs are non-specific, and infected animals may appear normal. For public aquariums, the major risk is therefore introduction: a consignment can pass visual inspection while carrying a virus capable of infecting several species. A 2026 study describes two rapid LAMP assays targeting the megalocytivirus major capsid protein gene. The result is relevant to screening, but remains analytical and preliminary.

The defensible response is not to replace laboratory PCR immediately with a tank-side test. Origin records, independent quarantine, sampling design, a validated method and a pre-agreed response to results must operate together. Speed adds value only inside that system.

Several viral groups sit behind one genus name

The genus Megalocytivirus in the family Iridoviridae includes groups associated with red sea bream iridovirus (RSIV), infectious spleen and kidney necrosis virus (ISKNV) and turbot reddish body iridovirus (TRBIV). Host range, geographic distribution and regulatory relevance are not identical across these viruses. International movements of freshwater ornamental fish have been implicated in the distribution of ISKNV and related viruses.

Infection may be associated with lethargy, reduced appetite, pale gills, darkening, haemorrhage or mortality. None is pathognomonic. Similar findings occur with water failures, transport stress and many other infections. Conversely, subclinical carriage makes the absence of visible signs weak reassurance in a high-risk group.

The World Organisation for Animal Health currently lists infection with Megalocytivirus pagrus1 and provides Aquatic Code and Manual chapters for red sea bream iridoviral disease. This does not mean that every ISKNV signal in every tropical fish triggers identical obligations. The competent authority must be consulted for the territory, host, origin, destination and virus concerned.

What the new LAMP assays actually evaluated

Sakuna and colleagues designed primers against a conserved region of the MCP gene to cover RSIV, ISKNV and TRBIV groups. Loop-mediated isothermal amplification operates at a constant temperature. A visual format uses a colour change, while a real-time format records fluorescence.

Under the reported conditions, visual LAMP detected 10 pg of synthetic template within 30 minutes. Real-time LAMP detected 10 ng at around ten minutes. These values should not be ranked as if they were clinical sensitivity estimates in fish. They are analytical detection results obtained with different formats and test material.

The sample set is the central limitation. Eighteen symptomatic bettas representing three phenotypes had already tested negative using a broad-range PCR assay. They were used to explore non-specific reactions. The positive target was chemically synthesised DNA based on reference sequences. No naturally positive fish were available to estimate field performance. Reported positive and negative percentage agreements therefore do not provide robust diagnostic sensitivity or specificity.

The authors explicitly call for larger field studies. Decision-grade deployment requires tests across viral loads, matrices and species, assessment of tissue inhibitors and cross-contamination, reproducibility between operators and concordance with a reference method.

Designing quarantine before selecting an assay

Quarantine should be physically and hydraulically independent from the main collection. Water circuits, nets, siphons, containers and protective equipment should be dedicated or disinfected under a demonstrated protocol. Staff and equipment flows should move from lower- to higher-risk areas without an unplanned return route.

Risk assessment starts with history: species and numbers, supplier, country and facility of origin, transport mortality, prior mixing and available health results. This information determines which agents and sampling strategies deserve priority. A standard panel for every consignment may miss a material risk while creating uninterpretable testing.

Sampling must reflect pathogen distribution. A negative external swab is weak evidence when a virus is detected more reliably in internal tissues. In sick fish or freshly dead specimens, necropsy, histopathology and molecular sampling can link detection with lesions and a plausible cause. For valuable live animals, non-lethal options should be agreed with the laboratory alongside honest estimates of their limitations.

Interpreting results without contaminating the decision

A positive result should be confirmed under the laboratory protocol, particularly when it could lead to euthanasia, rejection of a consignment or official reporting. Controls, target identity and, where appropriate, sequencing or an independent method matter. Detecting a conserved megalocytivirus sequence may not resolve the genotype or show that infectious virus is present.

A negative result belongs to a date, animal set, tissue and method. Low viral load, early infection, poor sample choice or inhibition can all cause non-detection. Quarantine should therefore end against predefined release criteria combining a suitable period, daily observations, mortality records, examination and testing—not one negative tube.

Conclusion

Megalocytiviruses show why appearance cannot protect a collection. The 2026 LAMP work offers a route towards faster screening, but its synthetic positive target and absence of naturally positive samples prevent it from being treated as a validated replacement. Independent quarantine, risk-based sampling and coordinated interpretation with laboratories and authorities remain the priorities.

How Vetofish can help

Vetofish can assess introduction risks, design quarantine flows, coordinate laboratory sampling, interpret PCR and histopathology within the clinical context, and define response options before results arrive. Advance planning prevents an urgent test from producing an improvised decision.

Need to plan a diagnostic investigation?

Let’s identify the samples and tests suited to your situation.

Discuss a case